The impact of COVID-19 on biotech/pharma service providers.
The Team at Zymewire took advantage of their unique position in the life sciences space to survey their client base regarding the impact of COVID-19 on their operations and business outlook.
TrialStat had an opportunity to participate in the survey and the results are out. It’s resoundingly clear that the pandemic is impacting all aspects of Clinical Trials but there are definitely some interesting insights hiding within these results.
Have a look at the survey results by clicking the button below to download the PDF!
Discover What Sets TrialStat Apart From Ordinary EDC Platforms
Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?